Net Profit Margin
since 2005
Calculation
Boston Scientific Corp., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income (loss)1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 5.50% | = | 100 | × | 698) | ÷ | 12,682) |
| Dec 31, 2021 | 8.76% | = | 100 | × | 1,041) | ÷ | 11,888) |
| Dec 31, 2020 | -0.83% | = | 100 | × | (82) | ÷ | 9,913) |
| Dec 31, 2019 | 43.78% | = | 100 | × | 4,700) | ÷ | 10,735) |
| Dec 31, 2018 | 17.01% | = | 100 | × | 1,671) | ÷ | 9,823) |
| Dec 31, 2017 | 1.15% | = | 100 | × | 104) | ÷ | 9,048) |
| Dec 31, 2016 | 4.14% | = | 100 | × | 347) | ÷ | 8,386) |
| Dec 31, 2015 | -3.20% | = | 100 | × | (239) | ÷ | 7,477) |
| Dec 31, 2014 | -1.61% | = | 100 | × | (119) | ÷ | 7,380) |
| Dec 31, 2013 | -1.69% | = | 100 | × | (121) | ÷ | 7,143) |
| Dec 31, 2012 | -56.12% | = | 100 | × | (4,068) | ÷ | 7,249) |
| Dec 31, 2011 | 5.79% | = | 100 | × | 441) | ÷ | 7,622) |
| Dec 31, 2010 | -13.64% | = | 100 | × | (1,065) | ÷ | 7,806) |
| Dec 31, 2009 | -12.52% | = | 100 | × | (1,025) | ÷ | 8,188) |
| Dec 31, 2008 | -25.29% | = | 100 | × | (2,036) | ÷ | 8,050) |
| Dec 31, 2007 | -5.92% | = | 100 | × | (495) | ÷ | 8,357) |
| Dec 31, 2006 | -45.74% | = | 100 | × | (3,577) | ÷ | 7,821) |
| Dec 31, 2005 | 10.00% | = | 100 | × | 628) | ÷ | 6,283) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
- Net Income (Loss) Trend
- Net income exhibited significant volatility over the period, with large losses reported in several years, notably in 2006, 2008, and 2012, where losses exceeded US$3 billion. Positive net income was noted in years such as 2005, 2011, 2016, 2018, and particularly in 2019 with a peak of US$4.7 billion. However, the company also reported negative net income in 2020, followed by moderate recovery in 2021 and 2022. The overall trend shows a pattern of fluctuations with intermittent strong recoveries and setbacks.
- Net Sales Evolution
- Net sales steadily increased over the timeframe, growing from US$6.3 billion in 2005 to US$12.7 billion in 2022. Despite minor declines or stagnations in certain years, such as from 2007 to 2009 and again in 2014 to 2016, the long-term trajectory reflects consistent growth. The sales figures demonstrate resilience and overall expansion of revenue-generating capacity.
- Net Profit Margin Behavior
- Net profit margin experienced dramatic swings, moving between positive and negative values. The margin was positive in initial years (10% in 2005), turned sharply negative during 2006 (-45.7%) and several subsequent years, with particularly severe declines in 2008 (-25.3%) and 2012 (-56.1%). Positive margins reappeared intermittently, with a notable peak in 2019 at 43.8%, indicating a highly profitable year. More recently, margins settled to moderate positive levels of 8.8% in 2021 and 5.5% in 2022. This volatility suggests periods of operational or financial challenges countered by occasional profit surges.
- Summary of Financial Health
- The company displayed significant earnings instability, with frequent fluctuations between net losses and profits. Nevertheless, net sales growth remained consistent, indicating a strong market presence and revenue growth capability. Profitability margins showed high variability but tended to improve in the latter years, signaling potential stabilization and improved operational efficiency. The data suggest ongoing challenges in maintaining consistent profitability despite rising sales volumes.
Comparison to Competitors
Boston Scientific Corp., net profit margin, long-term trends, comparison to competitors
| Boston Scientific Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 5.50% | 15.88% | 1.29% | 3.87% | 21.25% | 15.90% | 6.25% |
| Dec 31, 2021 | 8.76% | 16.42% | 2.72% | 4.46% | 29.85% | 11.97% | 6.06% |
| Dec 31, 2020 | -0.83% | 12.99% | 2.68% | 3.78% | 24.33% | 16.56% | 6.03% |
| Dec 31, 2019 | 43.78% | 11.56% | 2.59% | 4.66% | 30.80% | 15.16% | 5.76% |
| Dec 31, 2018 | 17.01% | 7.74% | -0.31% | 4.11% | 30.29% | 10.36% | 5.33% |
| Dec 31, 2017 | 1.15% | 1.74% | 3.58% | 4.31% | 21.09% | 13.56% | 5.28% |
| Dec 31, 2016 | 4.14% | 6.71% | 3.00% | 2.93% | 27.21% | 12.27% | 3.81% |
| Dec 31, 2015 | -3.20% | 21.68% | 3.42% | 3.27% | 24.69% | 13.20% | 3.72% |
| Dec 31, 2014 | -1.61% | 11.28% | 3.33% | 3.52% | 19.65% | 18.02% | 4.33% |
| Dec 31, 2013 | -1.69% | 11.79% | 3.62% | 3.55% | 29.62% | 20.90% | 4.62% |
| Dec 31, 2012 | -56.12% | 14.95% | 3.15% | 4.37% | 30.14% | 22.35% | 5.03% |
| Dec 31, 2011 | 5.79% | 12.17% | 3.23% | 4.42% | 28.17% | 19.43% | 5.08% |
| Dec 31, 2010 | -13.64% | 13.15% | 3.55% | 4.99% | 27.02% | 19.59% | 4.95% |
| Dec 31, 2009 | -12.52% | 18.68% | 3.74% | 7.80% | 22.11% | 14.86% | 4.42% |
| Dec 31, 2008 | -25.29% | 16.53% | 3.67% | 4.04% | 23.35% | 16.51% | 3.70% |
| Dec 31, 2007 | -5.92% | 13.92% | 3.45% | 5.56% | 24.06% | 22.78% | 6.26% |
| Dec 31, 2006 | -45.74% | 7.64% | 3.12% | 5.52% | 19.33% | 22.55% | 5.89% |
| Dec 31, 2005 | 10.00% | 15.10% | 3.31% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Boston Scientific Corp., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Boston Scientific Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2022 | 5.50% | 4.95% |
| Dec 31, 2021 | 8.76% | 5.52% |
| Dec 31, 2020 | -0.83% | 5.26% |
| Dec 31, 2019 | 43.78% | 5.25% |
| Dec 31, 2018 | 17.01% | 3.79% |
| Dec 31, 2017 | 1.15% | 4.90% |
| Dec 31, 2016 | 4.14% | 4.11% |
| Dec 31, 2015 | -3.20% | 4.94% |
| Dec 31, 2014 | -1.61% | 4.88% |
| Dec 31, 2013 | -1.69% | 5.40% |
| Dec 31, 2012 | -56.12% | 6.33% |
| Dec 31, 2011 | 5.79% | 6.03% |
| Dec 31, 2010 | -13.64% | 6.35% |
| Dec 31, 2009 | -12.52% | 6.98% |
| Dec 31, 2008 | -25.29% | 5.85% |
| Dec 31, 2007 | -5.92% | 6.89% |
| Dec 31, 2006 | -45.74% | 6.33% |
| Dec 31, 2005 | 10.00% | 7.71% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Boston Scientific Corp., net profit margin, long-term trends, comparison to industry (health care)
| Boston Scientific Corp. | Health Care | |
|---|---|---|
| Dec 31, 2022 | 5.50% | 11.62% |
| Dec 31, 2021 | 8.76% | 12.42% |
| Dec 31, 2020 | -0.83% | 8.45% |
| Dec 31, 2019 | 43.78% | 11.58% |
| Dec 31, 2018 | 17.01% | 9.92% |
| Dec 31, 2017 | 1.15% | 8.05% |
| Dec 31, 2016 | 4.14% | 10.68% |
| Dec 31, 2015 | -3.20% | 11.77% |
| Dec 31, 2014 | -1.61% | 12.15% |
| Dec 31, 2013 | -1.69% | 12.81% |
| Dec 31, 2012 | -56.12% | 11.86% |
| Dec 31, 2011 | 5.79% | 10.50% |
| Dec 31, 2010 | -13.64% | 10.48% |
| Dec 31, 2009 | -12.52% | 15.08% |
| Dec 31, 2008 | -25.29% | 11.35% |
| Dec 31, 2007 | -5.92% | 11.02% |
| Dec 31, 2006 | -45.74% | 13.95% |
| Dec 31, 2005 | 10.00% | 13.38% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).